Investor Presentation • May 29, 2024
Investor Presentation
Open in ViewerOpens in native device viewer





Strategy & Targets
Financial Results
Segment Breakdown
Appendix
Glossary



| Leading Israeli financials group |
472 NISb AUM1 |
TA-35 Leading index |
||
|---|---|---|---|---|
| Distinctive performance |
19% AUM CAGR 5-years2 |
15% ROE 5-year average2 |
||
| Strong capital position |
194% Solvency II Ratio3 |
At least 40% Dividend payout |
||
| Recognized stability |
AA / AAA Israel ratings4 Holding / Insurance |
A2 / A International ratings4 Insurance |
||
| Market Leadership |
Insurance Motor, Investment Policies |
Asset Management AUMs, Distribution, ETFs |

1Includes all activities including insurance as of March 31,2024
2 Five-year period (EOY 2018-23), acquisitions included
3Solvency with transitional measures as of December 31, 2023
4Israeli ratings: ilAA for Phoenix Holdings & ilAAA for Phoenix Insurance by S&P Maalot, Aa2.il for Phoenix Holdings & Aa1.il for Phoenix Insurance by Midroog; international ratings include Moody's A2 with negative outlook and S&P A- with a stable outlook
5 Adjusted EBITDA calculated as earnings before interest, tax, depreciation & amortization; consolidated before minority interests; adjusted for non-operating items, without IFRS 16 influence, and cash items relevant to specific segments (Retirement includes DAC amortization, Credit includes finance expense & provisions); 763 NISm without minority interest



Resilience in face of 2023 headwinds (war, political uncertainty, inflation, rates)
Continued uncertainty in 2024 impacting markets


GDP per Capita 3 USD '000 56 53 52 49 38 Germany Sweden UK Israel Italy

Long-Term Yields (10Y) 6 Percent 1.0 0.9 1.3 3.6 3.9 4.5
Unemployment 7 Percent

Note: Figures are updated as needed to reflect changes in assessments & methodologies
1Israel Securities Authority
2Israel Central Bureau of Statistics, forecast from Bank of Israel (real GDP growth, seasonally adjusted annual rate)
3 IMF for 2023, current USD, as of 2023, not PPP adjusted
4 Bank of Israel; includes funds managed by institutional investors; 2022 decline due to yields
5 Israel Central Bureau of Statistics, annual inflation, last twelve months; forecast from Bloomberg
6Bloomberg; long-term yields based on Israel 10-year government bond (not CPI-linked), for the last month of the period 7Bloomberg, IMF; end of period unemployment



Comprehensive Income ROE AUM


Shareholder Equity

Solvency*
Strong growth in Asset Management & Credit activities, including continued growth in income / EBITDA as well as organic & inorganic AUM growth
Insurance core income stability with growth in P&C but lower financial margin from equity
Resilience in face of continued uncertainty
of annual comprehensive income, facilitated by diverse cash flows & strong financial position including Solvency II, ratings, liquidity (insurance subsidiary policy increased to 40-60% payout)
Reaching 2025 targets with updated medium-term growth targets to be published



Notes: Core Income and Core ROE do not include Non-Operating Income: investment yields and variable management fees above or below 3% real yields, interest rate effects, and special items. Services income includes Asset Management (Pension & Provident, Investment Services), Distribution (Agencies), and Credit (Gama). For the convenience of the presentation, the statutory tax rate for taxable income for each activity is used, while the difference between the actual tax and the statutory tax is recorded in Special Items; see Glossary for definitions


Percent (nominal)

Percent (March 31, 2024)

Mark to market reporting transparency (reporting volatility) Group plans based on 3% real returns and stable rates
Team of over 100 investment professionals managing corporate account and client assets
Investing in capabilities including international investments and
technology platforms
Investment performance & track record Responsible allocation & risk management
Proactive and proprietary dealflow and sourcing
Balanced asset allocation
International investments with leading partners, co-investments, & direct positions
Responsible asset and liability management

* Five-year period (2019-23), based on known CPI LTM change as of end of period

265 NISm dividend from 2023 earnings distributed in April
Update of dividend policy to at least 40% payout (previously at least 30%) facilitated by diverse cash flows & strong financial position including Solvency II, ratings, liquidity; update of insurance subsidiary policy to 40-60% payout ratio (previously 30-50%)
54 NISm buybacks executed in 2024 to date

| Comprehensive Income | 512 | 664 | 1,353 | 2,316 | 1,124 | 1,093 | 284 | |
|---|---|---|---|---|---|---|---|---|
| Dividends from annual income (including in subsequent calendar year) | 120 | 480 | 380 | 621 | 337 | 385 | - | Dividend |
| Dividends distributed (during calendar year) | 120 | 480 | - | 580 | 581 | 297 | 265 | track |
| Dividends per share (during calendar year) | 1.0 | 1.9 | - | 2.3 | 2.3 | 1.2 | 1.05 | record |
| Buybacks executed | 26 | 74 | 56 | 38 | 54 |
Shareholders' Equity NISm


Financial Results
Segment Breakdown
Appendix
Glossary




Core Income
Updated growth targets and
roadmap to be published




Grow core income
Increase performance stability and liquidity (mix, IFRS-17, investments)
Shift mix to stable, high-margin activities (fee-based, high growth, high multiples)
Note: Mid-term Targets based on 5-year plan 2020-25 and assuming 3% return on investments. ROE target range assumes 3-5% real return on Nostro investments. Actual performance will depend on financial markets, macroeconomic growth, industry trends, company performance and other variables
* Average real yield over five years (2019-23) was 3.9%
Group priorities
** Based on 3% real return on investments without non-operating income




Including Smart direct, NISb Ratio

| P&C | Health | |||||
|---|---|---|---|---|---|---|
| % of premiums | ||||||
| 2019 | 4.10% | 5.57% | 0.50% | |||
| 2020 | 5.08% | 5.82% | 0.49% | |||
| 2021 | 4.40% | 5.50% | 0.41% | |||
| 2022 | 3.53% | 5.00% | 0.40% | |||
| 2023 | 3.46% | 5.13% | 0.39% | |||
| Q1-24 | 2.98% | 6.74%3 | 0.37% | |||
| 3.4-3.7% | 5.4-5.8% | 0.27-0.30% | ||||
| Mid-term target (2025) |

Without transitionals
Insurance
priorities
Efficiency & digitization
Reduced income volatility (mix, IFRS-17, investments)
Focused growth in capital-efficient, high-margin activities
Advanced capabilities
1 Solvency ratio with transitional measures; target range based on reduced transitional measures over time
2 Expenses as percent of gross earned premiums (P&C and Health) and AUMs (Life); expenses include general and administrative expenses, as well as other expenses; Health mid-term targets without HMO activity
Note: Mid-term Targets based on 5-year plan 2020-25 and assuming 3% real return on investments
3 Health expense ratio increase due to reduced premiums from ending of LTC collective HMO agreement & product / regulatory transition, however mid-term targets remain unchanged



Investment House includes acquisitions of Psagot active & money market funds
producing significant EBITDA from non-insurance businesses
Strategy focused on accelerated growth, with strong organic capabilities & proactive acquisitions – doubling EBITDA in 3 years
236 NISm adjusted EBITDA not including minority interest in Q1 2024; 763 NISm in 2023 (full year)
8 NISm from above average brokerage margin spreads in Q1 2024
NISm, consolidated including minorities

Note: Adjusted EBITDA calculated as earnings before interest, tax, depreciation & amortization; consolidated before minority interests; adjusted for non-operating items, without IFRS 16 influence, and cash items relevant to specific segments (Retirement includes DAC amortization, Credit includes finance expense & provisions)

750

2022
2020 2021 2023 Q1-24
Retirement (Pension & Provident)

Investment House & Wealth Revenues NISm 763 666 502 463

Approaching targets Achieving targets
target


cash-generative & capital-light business model, market leader but still low 6% market share1 ; value creation through growth, scale, innovation, and diversification
Independent agencies with experienced management (aligned with equity), providing access to all carriers / managers
Client-focused activities include benefit administration, retirement planning, & insurance (life, health, P&C, specialties)
Aggregator platform with scale & infrastructure to support small agents; independent IT infrastructure & efficient digital platforms
Assessing interest from international investors to unlock & create value

Approaching targets

AM&C: Private Credit (Business and Consumer)
100% ownership following tender offer in 2023 (continues to report with publicly traded bonds); building platform for growth (e.g., balance sheet, governance, infrastructure, capabilities); based on Gama's broad SME relationships Israel rating updated to Aa3.il with positive outlook
Merged into Phoenix-Gama in January 2024, creating synergies, economies of scale & expertise to be realized in 2024-25
Built 2022-23, launching in 2024

Phoenix Holdings has several credit activities - Gama is the primary platform and is included in the Credit Segment, but in addition several other activities provide credit from corporate account (Nostro) funds or invest in fixed income instruments and are not included in the Credit Segment





Q1 2024, NISm

NISm
| Q1/24 | Q1/23 | Difference | |
|---|---|---|---|
| P&C | 174 | 112 | 62 |
| Health | 35 | 36 | (1) |
| Life Savings & |
59 | 47 | 12 |
| Other Equity Returns |
23 | 109 | (86) |
| Core Insurance |
291 | 304 | (13) |
| (Pension Provident) Retirement & |
30 | 24 | 6 |
| Investment House & Wealth |
78 | 57 | 21 |
| Distribution (Agencies) |
74 | 66 | 8 |
| Credit | 36 | 28 | 8 |
| Other | 0 | (6) | 6 |
| Core Asset Management & Credit |
218 | 169 | 49 |
| Income (*) Investment |
104 | (467) | 571 |
| P&C | 37 | (54) | 91 |
| Health | 32 | 15 | 17 |
| Life | (72) | (139) | 67 |
| Other Equity Returns |
108 | (292) | 400 |
| (Pension Provident) Retirement & |
1 | (4) | 5 |
| Distribution (Agencies) |
(2) | 7 | (9) |
| Interest | (111) | 150 | (261) |
| P&C | 42 | 18 | 24 |
| Health | (117) | 106 | (223) |
| Life | (36) | 26 | (62) |
| Special Items |
(49) | (24) | (25) |
| P&C | (2) | 0 | (2) |
| Health | (12) | (7) | (5) |
| Life | (34) | (11) | (23) |
| Other Equity Returns |
10 | 0 | 10 |
| Retirement (Pension & Provident) |
0 | 0 | 0 |
| Investment House & Wealth |
(6) | (6) | 0 |
| Distribution (Agencies) |
0 | 0 | 0 |
| Credit | (5) | 0 | (5) |
| Other | 0 | 0 | 0 |
| Non-operating Income |
(56) | (341) | 285 |
* Investment income and variable management fees above 3% annual return and after offsetting guaranteed yields (where relevant)
** Negative impact of interest rates mainly due to decrease in the illiquidity premium

Q1 2024, NISm


| Phoenix Holdings NISm |
31/12/2023 | 31/03/2023 | 31/03/2024 | Difference | Financial Liabilities (NISm) |
|||||
|---|---|---|---|---|---|---|---|---|---|---|
| Bonds and Loans |
||||||||||
| Cash | 3,053 | 2,268 | 2,729 | -324 | 31/03/2024 | 31/12/2023 | ||||
| Intangible Assets |
3,598 | 3,061 | 3,740 | 142 | CPI | Floating | Fixed | |||
| Deferred acquisition costs |
2,686 | 2,594 | 2,752 | 66 | linked | interest | interest | Total | Total | |
| Investments in associates |
1,652 | 1,618 | 1,918 | 267 | ||||||
| Investment - other property |
1,239 | 1,148 | 1,298 | 59 | Solo* Holdings |
962 | 397 | 543 | 1,902 | 1,896 |
| Credit for purchase of securities |
3,700 | 3,439 | 4,255 | 555 | Insurance | |||||
| Other Assets |
8,326 | 7,619 | 8,425 | 99 | Tier capital 1 |
219 | - | - | 219 | 218 |
| Other Financial Investments |
30,771 | 30,901 | 29,964 | -807 | Tier capital 2 |
750 | 492 | 2,844 | 4,086 | 4,067 |
| Assets for yield-dependent contracts |
104,770 | 97,696 | 103,027 | -1,742 | Insurance Total |
969 | 492 | 2,844 | 4,305 | 4,684 |
| Total Assets |
159,795 | 150,343 | 158,109 | -1,685 | ||||||
| Financial liabilities |
Retirement | - | 477 | - | 477 | - | ||||
| Liabilities in of non-yield-dependent respect |
15,576 | 14,779 | 13,941 | -1,635 | Credit | - | 1,144 | 215 | 1,359 | 1,438 |
| insurance and investments contracts |
Distribution | - | 372 | - | 372 | 300 | ||||
| contracts | 25,597 | 24,691 | 27,601 | 2,003 | Investment House & Wealth |
- | 581 | - | 581 | 263 |
| Liabilities in of yield-dependent respect |
AM&C Total |
- | 2,574 | 215 | 2,789 | 2,001 | ||||
| insurance and investments contracts |
Total bonds and loans |
|||||||||
| contracts | 102,973 | 96,025 | 100,652 | -2,321 | 1,930 | 3,463 | 3,602 | 8,996 | 8,582 | |
| Other Liabilities |
4,753 | 4,431 | 5,023 | 269 | Exposure Ratio |
21% | 39% | 40% | 100% | 100% |
| - | Other Derivatives Repo & |
(Nostro)** | 2,477 | 2,921 | ||||||
| Total equity |
10,895 10,416 |
10,893 | -2 | , Other Derivatives Repo & |
linked)** (Unit |
752 | 2,240 | |||
| - | , Credit (Gama) cards liabilities |
1,716 | 1,755 | |||||||
| Total equity and liabilities |
159,795 | 150,343 | 158,109 | -1,685 | Total | 13,941 | 15,497 |
Net financial debt exposure includes financial assets & only some of the financial liabilities (see 2024 Q1 Financial Statements Section – Section 5.7.2 in the BOD Report) Liabilities include use of derivatives opposite relevant financial assets for operational purposes (e.g., Insurance, Investment House) and Gama financing for credit portfolio and improved capital structure


| With transitionals | 211% | 205% | 194% | |
|---|---|---|---|---|
| Without transitional | 149% | 153% | 152% | |
| BOD dividend threshold | 111% | 115% | 115% | |
| 14.7 | 14.7 | 14.8 | ||
| Surplus | 7.8 | 7.5 | 7.2 | |
| SCR | 6.9 | 7.2 | 7.6 | |
| 12.22 | 6.23 | 12.23 |
Solvency II implemented in Israel in line with international standards, with strong regulatory oversight
Transitional measures through 2032, with natural offset from Phoenix backbook runoff (expected to release Solvency capital requirements and risk margin at least as high as transitional measures through 2032, reflecting the difference between Solvency ratio with and without transitional measures)
Standard model used (internal models not allowed)
Phoenix Solvency does not include group equity outside Insurance Company; significant additional group capital resources held under Phoenix Holdings
Quarterly publication of Solvency ratio with one quarter delay; full breakdown for Q2 and Q4, with only transitional headline figure for Q1 and Q3
194% with transitional measures as of December 2023
Insurance Company BOD dividend threshold 115% without transitionals, while excess capital above 115% was 3.1 NISb (as of December 2023)
December 2023 transitional figures include 5% decrease due to update of transition numbers
Insurance subsidiary dividend payout updated to 40-60% of comprehensive income, in line with solvency target range
Services generate significant cash from fee-based income (e.g., asset management, agencies)
Strong liquidity at holding level including Phoenix Insurance Tier 1 capital notes of 1.3 NISb (trading on Tel-Bond 40 index); sale of 140 NISm capital notes after reporting period
Insurance Company with international ratings (Moody's A2, S&P A-)
Moved 300 NISm Construction Finance, optimizing capital
IFRS 17 & IFRS 9 implementation in 2025, expected to reduce volatility
Dynamic management of market exposures





20% growth in earned premiums YOY
Improved performance including in motor despite challenging environment & high rates of theft
Mature implementation of machine learning for motor underwriting
Positive secondary impact of interest rates
NISm

Note: Core income assume a real rate of return of 3%, investment income includes income from corporate account (Nostro) above or below a 3% real return; Q4 Core Income from underwriting of 328 NISm was based on 114 NISm from Compulsory Motor, 51 NISm from Motor Property, 33 NISm from Property & Other, and 130 NISm from Liability



Investment margin improvement
LAT reserves mainly due to decrease in illiquidity premium; 228 NISm LAT reserves remaining as of March 2024
Maccabi HMO collective LTC agreement ended December 2023
NISm





mainly due to interest rates
Variable management fee deficit of 302 NISm as of report publication date
policies, however at slower rate due to capital market volatility
NISm




23 NISm financial margin, 86 NISm decrease due to changes in CPI
400 NISm increase in investment profit above 3% compare to Q1-2023




including higher margin / efficient activities
NISm



Performance improvement from strategic execution
Higher brokerage contribution due to continued client acquisition, average revenues & higher spreads in margin credit
in 2024, including Epsilon Investment House & assets from Psagot Investment House (including portfolio management and funds)
Comprehensive Income Before Tax NISm

Includes (1) Phoenix Investment House (formerly "Excellence") – active & passive mutual funds, ETFs, discretionary portfolios, private & institutional brokerage, & employee stock option administration; and (2) Phoenix Advanced Investments – alternative investment wealth platform focused on private client distribution of best-in-class managers
1-3/23



however growth rate impacted by slower pace of hiring in the market (including in tech sector)
Accelerated value creation under reorganized structure with synergies
Assessing interest from international investors to unlock & create value going forward

-


Full ownership of Gama following successful take-private tender offer in 2023, followed by merger of Phoenix Construction Finance in January 2024
Stability in most credit categories despite market conditions
Strong balance sheet with 32% Equity-to-Assets ratio*
Consumer credit to be launched in 2024
NISm, without credit card activity





Segment includes Phoenix Holdings solo profits (including RT1 holding) as well as other items
NISm


Glossary
Disclaimer


1
Strong long-term demographic & wealth trends with high compulsory savings rates, potential for greater penetration, and macro resilience

Leading financial services group with over \$120b AUM (including multi-line insurance, asset management, distribution, & credit), delivering best-in-class average 15% ROE and 19% AUM CAGR over the past 5 years

4
5
Significant share of income generated by Asset Management and Credit activities (recurring fee-based financial services businesses, cash-generative, capital-light), with plan to unlock value of assets currently held at book value
Focus on accelerating growth in high ROE businesses, innovation and technology for competitive advantage and efficiency, active management of businesses to unlock & create value, & disciplined capital management and deployment
Consistent growth in shareholder equity with a Solvency ratio of 209% (with transitional measures), at least 30% dividend distribution policy, and international insurance rating
6
Deep sector and broad functional experience at both board and management levels


Reconciliation of investment returns above / below 3% real returns with financial statements NISm
| Q1-24 | Q1-23 | 2023 | |
|---|---|---|---|
| from P&L Items Financial Statements |
|||
| income Investment |
5 769 , |
918 | 9 910 , |
| Share profits of equity-accouted in investees |
25 | 6 | 42 |
| Total of other comprehensive components net income |
66 | 138 | 306 |
| effect Tax |
51 | 63 | 147 |
| Subtotal | 5 911 , |
1 125 , |
10 404 , |
| Less: | |||
| (losses) relating yield-dependent policies Investment gains to |
5 276 , |
886 | 8 531 , |
| Investment gains (losses) relating investment services & credit to |
122 | 99 | 349 |
| Subtotal | 5 399 , |
985 | 8 881 , |
| Corporate (Nostro) total investment income account |
512 | 140 | 1 526 , |
| Corporate (Nostro) 3% real account investment income assuming returns |
399 | 593 | 2 291 , |
| (Nostro) investment income above (below) real Corporate 3% account returns |
113 | (453) | (765) |

Disclaimer



| Adjusted EBITDA | Adjusted EBITDA calculated as earnings before interest, tax, depreciation & amortization; consolidated before minority interests; adjusted for non-operating items and cash items relevant to specific segments (Retirement includes DAC amortization, Investment House & Wealth includes IFRS 16 amortization, Distribution includes IFRS 16 amortization, Credit includes IFRS 16 amortization & finance expense) |
|---|---|
| AM | Asset Management |
| AUM | Assets Under Management; the total market value of all the investments that are managed by the Group |
| Bps | Basis Points; 1 basis points is .01% |
| CGU | Cost Generating Unit |
| CI | Comprehensive Income |
| CLR | Combined Loss Ratio |
| CO | Corporate, Other and Consolidation |
| Core Income | Income from operations not including investment yields & variable fees above/below 3% real yields, interest rate effects, and special items |
| Core ROE | Core income as a percent of total equity |
| CPI | Consumer Price Index; measures the average change of prices in an agreed upon basket of consumer goods and services over time |
| CSM | Contractual Service Margin |
| D&O | Directors and Officers Liability Insurance |
| DAC | Deferred Acquisition Cost |
| ESOP | Employee Stock Ownership Plan; workplace benefit program, that provides the employees with ownership interest in the company. |
| ETF | Exchange Traded Fund; an open end, tradable basket of securities that tracks an underling index, sector, or security type |
| Fixed-Rate Gov Bonds | A government issued bond for which the interest income payment is agreed upon and does not change |
| FX | Foreign Exchange Currency |
| Gama | Financial services and credit company owned by the Phoenix Group |
| Halman corporate funds | Israeli Electric Company (IEC) |
| Illiquidity Premium | Or Liquidity Premium; premium demanded by investors when any given security cannot be easily converted into cash for its fair market value. |
| IMF | International Monetary Fund |
| Insurance Core Income | Core Income from insurance activities |
| Index Linked Gov Bonds | A government issued bond for which the interest income payment is related (or linked) to the CPI |
| LAT | Liability Adequacy Test |
| Liquidity Premium | See Illiquidity Premium |
| LOB | Line of Business |
| LTC | Long Term Care insurance; typically helps pay for costs associated with long term care |
| LTS | Long Term Services; including but not limited to Life, Provident and Pension funds |
| Marketable Securities | Liquid financial assets that can be quickly converted into cash; most are trading assets |
| MF | Management Fees; wages charged by a financial manager |
| Moody's | A credit risk rating agency |

| Mutual Fund Open end, non-tradable basket of securities that tracks the performance of an undelaying index, sector, or security type Net Inflows The net amount of new cash, excluding the impact of investment market value; calculated by subtracting withdrawals from new deposits NIS New Israeli Shekel Asset group that is considered to be difficult to buy or sell due to the fact they are not traded on any major exchange; could include government issued debt Non-Marketable Securities securities, limited partnerships, real estate investments and more Non-Operating Income Impact on income of investment yields & variable fees above/below 3% real yields, interest rate effects, and special items Nostro The account in which a financial institution manages its own funds OPEX Operational Expenses P&C Property and Casualty insurance PH Phoenix holdings PHI Permanent Health Insurance PI Phoenix insurance PLI Professional Liability insurance Reinsurance A balancing risk strategy; one or more insurers that share the liability Revenue All encompassing streams of income; including, but not limited to: premium, management fees, benefit contributions RFR Risk Free Rates ROE Return On Equity; calculated by dividing net income over total equity Services Core Income Core Income from Services activities including asset management, distribution, and credit SME60 "The Rest Index"; tracks the performance of the 60 largest market value companies that are excluded from the Tel Aviv Stock Exchange Changes in profit or loss that are not part of the usual business of the Company, including changes in actuarial research, actuarial model changes, other Special Items structural changes and strategic acquisition costs in AM segment |
|---|
| Tel Bond 20 Index that tracks the performance of the 20 largest Index Linked Corporate Bonds in terms of market value |
| Tel Bond 40 Index that tracks the performance of the 40 largest Index Linked Corporate Bonds in terms of market value |
| Tel Bond 60 Index that tracks the performance of the 60 largest Index linked Corporate Bonds in terms of market value |
| TLV 125 An index that tracks the performance of the 125 largest market value companies in the Tel-Aviv Stock Exchange |
| TLV 35 An index that tracks the performance of the 35 largest market value companies in the TLV Stock Exchange |
| TLV 90 An index that tracks the performance of the 90 largest market value companies in the TLV stock Exchange |
| TMTP Transitional Measures on Technical Provisions |
| Workers' Compensation Insurance Insurance coverage for employees' injuries or sickness |
| Yield Curve A line that plots interest rates of bonds with equal credit risk with different maturity dates in the future |

Glossary
Disclaimer



This presentation does not constitute an offer to purchase the Company's securities or solicitation to receive such offers and is designed solely to offer information as part of the Company's explanations regarding its Financial Statements.
This presentation includes information regarding the Company's strategic plan as well as forward-looking information as defined in section 32A of the Securities Law 5728-1968.
The realization and/or non-realization of forward-looking information which is stated in the financial reports and this presentation will be affected by risk factors that characterize the activities of the Company and group companies, as detailed in the Company's periodic reports, including changes in economic conditions, capital market in Israel and globally, the development of competition in the segments relevant to the group's activities, regulatory changes, changes in consumer preferences and consumption habits, changes in working assumptions or in the economic models and assumptions, and changes in implementation or execution – that can not be estimated in advance and may not be controlled by the Company. Hence, there is no certainty that the actual results and achievements of the Company in the future will be in accordance with these views and may differ, also substantially, from those presented in this presentation.
Furthermore, the presentation includes data and assessments based on external sources, the contents of which were not independently tested by the Company and therefore the Company is not responsible for their accuracy.
This presentation was drafted for the sake of convenience and needs to be reviewed along with the Company's public reports, including the Financial Statements, which contain the complete information about the Company, before making any decision to invest in the Company's securities.
This presentation may include information that is presented differently from the way it was presented in the company's official reports, some information may be presented and/or categorized and/or edited and/or segmented differently from the company's official past reports.
For the avoidance of doubt, the Company does not undertake to update or change the information contained in this presentation.

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.